McDermott advises shareholders of Medical Imaging Specialists FotoFinder Systems on sale of majority stake to EMZ Partners

Munich, May 19, 2022 – McDermott Will & Emery has advised the founders and existing shareholders of FotoFinder Systems GmbH on the sale of a majority stake in their company to EMZ Partners. The shareholders will take a significant equity stake back and continue the business.

FotoFinder Systems GmbH, founded in 1991 and headquartered in Bad Birnbach (Bavaria), is a leading provider of visualization technology for early skin cancer detection and aesthetic treatment.

The private equity firm EMZ Partners, with offices in Paris and Munich, focuses on investing alongside founders, family shareholders and managers and has invested in more than 130 medium-sized companies over the past 20 years.

The closing of the transaction took place at the end of April 2022.

The team advising the shareholders was led by Carsten Böhm and included Nina Siewert, Nils Christian Wighardt, Marcus Fischer, Steffen Woitz, Christian Krohs, Benjamin Maciejewski, LL.M., Dr. Fabian Appadoo, Sebastian M. Gerstner, Isabella Denninger, Max Küttner.

McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices, industries and more than 20 locations to deliver highly effective—and often unexpected—solutions that propel success. More than 1,200 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.